UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000044375 |
|---|---|
| Receipt number | R000050571 |
| Scientific Title | AN OBSERVATIONAL STUDY OF EFFECTIVENESS AND SAFETY OF THE FIRST LINE NIVOLUMAB PLUS IPILIMUMAB WITH OR WITHOUT CHEMOTHERAPY FOR ADVANCED / RECURRENT NON-SMALL CELL LUNG CANCER IN JAPAN (LIGHT-NING) |
| Date of disclosure of the study information | 2021/05/31 |
| Last modified on | 2023/12/13 10:54:37 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/05/31 08:50:01 | ||
| 2 | Update | 2021/07/02 13:42:52 | Recruitment status |
|
| 3 | Update | 2022/12/01 14:15:30 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2022/12/01 16:11:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address TEL Name of person sending information Address Address TEL |
|
| 5 | Update | 2022/12/01 16:16:24 | Last follow-up date |
|
| 6 | Update | 2022/12/01 16:53:40 | Date of IRB |
|
| 7 | Update | 2023/12/13 10:53:29 | Recruitment status |
|
| 8 | Update | 2023/12/13 10:54:37 | Publication of results Number of participants that the trial has enrolled |
